title: Physiological genomics analysis for Alzheimer's disease.
abstract: Alzheimer's disease is a common kind of dementia. This disorder can be detected in all countries around the world. This neurological disorder affects millions of population and becomes an important concern in modern neurology. There are many researches on the pathogenesis of Alzheimer's disease. Although it has been determined for a long time, there is no clear-cut that this is a case with genetic disorder or not. A physiological genomics is a new application that is useful for track function to genes within the human genome and can be applied for answering the problem of underlying pathobiology of complex diseases. The physiogenomics can be helpful for study of systemic approach on the pathophysiology, and genomics might provide useful information to better understand the pathogenesis of Alzheimer's disease. The present advent in genomics technique makes it possible to trace for the underlying genomics of disease. In this work, physiological genomics analysis for Alzheimer's disease was performed. The standard published technique is used for assessment. According to this work, there are 20 identified physiogenomics relationship on several chromosomes. Considering the results, the HADH2 gene on chromosome X, APBA1 gene on chromosome 9, AGER gene on chromosome 6, GSK3B gene on chromosome 3, CDKHR1 gene on chromosome 17, APPBP1 gene on chromosome 16, APBA2 gene on chromosome 15, GAL gene on chromosome 11, and APLP2 gene on chromosome 11 have the highest physiogenomics score (9.26) while the CASP3 gene on chromosome 4 and the SNCA gene on chromosome 4 have the lowest physiogenomics score (7.44). The results from this study confirm that Alzheimer's disease has a polygenomic origin.
authors: Wiwanitkit House, Bangkhae, Bangkok, Thailand.
authors: Viroj
authors: V
authors: Wiwanitkit
keywords: Alzheimer's disease; physiogenomics; relationship
references: Microb Pathog. 2005 Jul-Aug;39(1-2):19-26
references: 15998578
references: Niger Postgrad Med J. 2006 Sep;13(3):247-55
references: 17278322
references: Curr Alzheimer Res. 2006 Dec;3(5):411-9
references: 17168640
references: Nat Genet. 2006 Feb;38(2):234-9
references: 16415889
references: Acta Physiol Scand. 2004 Aug;181(4):585-92
references: 15283774
references: FEBS Lett. 1996 Oct 7;394(3):279-84
references: 8830658
references: Neurol Clin. 2007 Aug;25(3):611-67, v
references: 17659183
references: BMC Genomics. 2006 Aug 09;7:202
references: 16899120
references: Genet Psychol Monogr. 1980 Feb;101(First Half):71-97
references: 7358271
references: Curr Alzheimer Res. 2004 May;1(2):135-42
references: 15975078
references: Andrologia. 2008 Jun;40(3):158-60
references: 18477202
references: J Physiol. 2004 Jan 1;554(Pt 1):46-55
references: 14678490
references: Acta Neurol Taiwan. 2008 Sep;17(3):214-6
references: 18975530
references: Pharmacogenomics. 2007 Dec;8(12):1735-45
references: 18086003
references: Biochim Biophys Acta. 2000 Jul 26;1502(1):133-8
references: 10899438
references: Neurochem Int. 2007 Jan;50(1):12-38
references: 16973241
references: Mamm Genome. 1998 Jun;9(6):473-5
references: 9585438
references: Neuroreport. 1999 Aug 20;10(12):2575-8
references: 10574372
references: J Gerontol A Biol Sci Med Sci. 2003 Apr;58(4):331-53
references: 12663697
references: Curr Psychiatry Rep. 2000 Apr;2(2):158-64
references: 11122949